Sanara MedTech (SMTI) Non-Current Deffered Revenue (2017)

Sanara MedTech (SMTI) posted Non-Current Deffered Revenue of $14138.0 for Q3 2017, down 1.51% on a QoQ basis from $14355.0 in Q2 2017.

Sanara MedTech (SMTI) Non-Current Deffered Revenue (2017) Analysis & Trends

Sanara MedTech's Non-Current Deffered Revenue history runs 1 years deep, the most recent figure standing at $14138.0 for Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 163.15 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 13.90 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 208.80 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Sanara MedTech 233.71 Mn 220.11 Mn 25.87 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 14,138.00
Jun 30, 2017 14,355.00